TikTok is cracking down on Ozempic content, which some GLP-1 creators say is punishing the community for a problem they’ve already been trying to fix.
    • @[email protected]English
      10•20 days ago

      I’d like to rent your home for a weekend, I’ve always wanted to try living under a rock.

    • NebLemEnglish
      6•20 days ago

      I’ve never heard if it either but I too am not on TikTok and I use ad-blockers nearly everywhere.

  • @[email protected]English
    6•20 days ago

    Maybe it’s my tinfoil hat that’s getting a bit tight here but…

    The Chinese are fighting an obesity epidemic like most of the western world, but they have to import all the GLP-1 drugs from companies outside China. They know this will cost a fortune, just look at the US with Novo’s ozempic/wegovy. But soon Eli Lilly will have a similar product on the market, and that will be the same for China. They’ll have to fork over billions to economic/political adversaries for these drugs, so they want to keep that under control. This is not because they care for anyone’s health and safety.

  • AutoTL;DRBEnglish
    2•21 days ago

    This is the best summary I could come up with:

    It wasn’t until Kane began scrolling on TikTok and engaging with other creators who took similar drugs — known as semaglutide, or GLP-1 medications — that she decided to “take the plunge” and get a prescription for Mounjaro.

    The company’s website states it wants the app to be “a place that encourages self-esteem and does not promote negative social comparisons.” When reached for comment by Rolling Stone, a TikTok spokesperson referred back to the new guidelines, saying the policies were mainly expanded to prevent the sale of weight loss or performance-enhancing drugs on the site — and they still allow for people to share their weight-loss journeys as long as they aren’t extreme, dangerous, or relating to using GLP-1 medications for weight loss.

    I have built a community of people who needed someone they could relate to, someone who didn’t shame this medication or put it down or make them feel bad about being overweight or struggling with obesity.”

    Since the new guidelines, Taylor has simply moved most of her content onto Instagram, where parent company Meta has more lenient rules about posts surrounding weight loss.

    Reports in The Washington Post and The New York Times have speculated that the new guidelines might be in response to the rise of compounded semaglutide, sales of which thrive on TikTok through affiliate link programs.

    Compounded versions of semaglutide are mixed by a pharmacist but not manufactured by a name-brand company, which the FDA has warned could cause adverse and dangerous side effects if made by a pharmacy with poor standards.

    The original article contains 1,396 words, the summary contains 256 words. Saved 82%. I’m a bot and I’m open source!